Why the study?
Does the use of multiple overlapping paclitaxel-eluting stents reduce revascularization and MACE in patients with long coronary lesions compared to uncoated stents?
Does the use of multiple overlapping paclitaxel-eluting stents reduce revascularization and MACE in patients with long coronary lesions compared to uncoated stents?
The use of multiple overlapping paclitaxel-eluting stents is safe and highly effective at reducing restenosis and the need for repeat revascularization in long, complex coronary lesions compared to bare-metal stents.
No takes yet. Share an insight, caveat, or question.
Supports paclitaxel-eluting stents for long lesions; extends DES efficacy to overlapping use in complex PCI.
Dawkins et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: